β受体阻滞剂作为高血压一线治疗药物的时代结束了吗?

被引:1
作者
马虹
机构
[1] 中山大学心血管病研究所
关键词
β受体; β型肾上腺素能受体; 阻滞剂; 森林阻火剂; 药物; 高血压; 一线治疗;
D O I
暂无
中图分类号
R972 [心血管系统药物];
学科分类号
1007 ;
摘要
引用
收藏
页码:8 / 9
页数:2
相关论文
共 5 条
[1]  
Expert con-sensus document onβ-andrenergic recepotor blockers.The task force on beta-Blockers of the European Society of Cardiology. Lopez-Sendon J,Swedberg K,McMurray J,et al. European Heart Journal . 2004
[2]  
Atenolol in hypertension:is it a wise choice. Bo Carlberg,Ola Samuelsson,Lars Hjalmar Lindholm. The Lancet . 2004
[3]  
Areβ-blockers efficacious as first-line therapy for hypertension in the elderly?A systematic review. Franz H Messerli,Ehud Grossman,Uri Goldbout. The Journal of The American Medical Association . 1998
[4]  
Should beta blockers remain first choice in the treatment of primary hypertension?A meta-analysis. Lindholm LH,Carlberg B,Samuelsson O. The Lancet . 2005
[5]  
Vascular development,pulse pressure,and the mechanisms of hypertension. Safar ME,Boudier HS. Journal of Hypertension . 2005